Being NON-DTC eligible is hurting this ticker, at least in the short term.
We all know about the TD Ameritrade issue. I think there has been a serious misuse of the word "chill" on their part. NSAV literally can not be on chill...they aren't in the DTC.
We need more retail investors...I know quite a few people in Canada who cannot buy and want but also don't want to setup an account with TD Webroker or Scotia iTrade up here in Canada. I believe as it stands, those are the only two brokerages that allow buying of NSAV. All others either recently stopped or haven't allowed buying for a few years now. All the lower fee'd brokerages don't trade it.
Not sure which others don't allow for NSAV to be bought in the US but I know TDA is huge.
I actually think that with all the news we've seen, with the launch of VB having zero impact on price share, that becoming DTC eligible and consequently having NSAV fully tradeable on these brokerages will be what gets us moving to where we should be. I think we should be at .05-.10 just on the strength of the news we have out.
Market Data 
Markets 
AI
